Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **urease enzyme catalytic site** is a highly conserved region within the urease protein responsible for catalyzing the hydrolysis of urea into ammonia and carbon dioxide. This reaction is crucial for nitrogen metabolism across a wide range of organisms including bacteria, fungi, and plants[2][4]. The **active site** features a unique bi-nickel center coordinated by several amino acid residues—most notably a carbamylated lysine that bridges both nickel ions—as well as histidines and an aspartate residue[4]. In bacterial ureases, access to this deeply buried active site is regulated by conformational changes in mobile flaps or loops that gate substrate entry and product release[1][3].\n\nThe mechanism involves nucleophilic attack on the urea molecule facilitated by one nickel ion while the other activates a water molecule for hydrolysis; this results in formation of ammonia and carbamate—the latter spontaneously decomposes into another ammonia molecule plus carbon dioxide[2][4]. The structural integrity of this catalytic core is essential for enzymatic function; disruption via mutation or metal chelation abolishes activity.\n\nUreases are important therapeutic targets particularly in pathogenic bacteria like *Helicobacter pylori*, where their activity enables survival under acidic conditions through local pH elevation—a key factor in infection persistence. Several small molecules—including acetohydroxamic acid—act as competitive inhibitors at this catalytic center.\n\nNo major safety concerns are directly associated with targeting the urease active site itself beyond general considerations related to off-target effects on host metalloenzymes if systemic inhibitors are used.\n\nIn summary, the **urease enzyme catalytic site** represents an archetypal example of a metalloenzyme’s functional core with broad biological significance spanning agriculture, medicine, microbiology, and environmental science[2][4][6].
Competitive inhibition at the bi-nickel active site by substrate analogs or transition-state mimics
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urease enzyme catalytic site.